Is the Two-minute Step Test an Alternative to the Six-minute Walk Test in Pulmonary Hypertension?
NCT07193173 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 35
Last updated 2026-05-07
Summary
The aim of this observational study is to evaluate the validity of the 2-minute step test in assessing functional capacity in pulmonary hypertension.
Conditions
- Pulmonary Hypertension
Interventions
- OTHER
-
2 minute step test
The 2-Minute Step Test (2MST) is a simple, validated field test used to assess aerobic endurance and functional fitness, especially in older adults or people with chronic conditions (e.g., cardiopulmonary disease, neurological disorders).
Sponsors & Collaborators
-
Saglik Bilimleri Universitesi
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-09-15
- Primary Completion
- 2026-06-15
- Completion
- 2026-06-25
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Retrospective Data Analysis of Data From the Zurich PH Registry
NCT03198910 ·Status: COMPLETED
-
Londrina Activities of Daily Living Protocol in Pulmonary Hypertension
NCT07206173 ·Status: COMPLETED
-
Assessing the Utility of Submaximal CPET in Treatment Management of PAH
NCT05977933 ·Status: NOT_YET_RECRUITING
-
Side Effects of Pulmonary Hypertension Medications
NCT01571713 ·Status: COMPLETED
-
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NCT07179380 ·Status: RECRUITING ·Phase: PHASE3
-
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension
NCT05147805 ·Status: COMPLETED ·Phase: PHASE2
-
Blood Markers Predict Effect of Normobaric Hypoxia at Rest and During Exercise in Patients With Pulmonary Hypertension
NCT04715113 ·Status: COMPLETED ·Phase: NA
-
Beta-blockers in Pulmonary Arterial Hypertension
NCT02507011 ·Status: TERMINATED ·Phase: PHASE2
-
Repeatability and Sensitivity to Change of Non-invasive Endpoints in PAH
NCT03841344 ·Status: UNKNOWN ·Phase: NA
-
TReatment of Pulmonary Hypertension Group II Study
NCT03611270 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NCT05649722 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Repurposing a Histamine Antagonist to Benefit Patients With Pulmonary Hypertension
NCT03554291 ·Status: COMPLETED ·Phase: PHASE2
-
Discovering Clinical Study Experiences of Patients With Pulmonary Hypertension
NCT05918458 ·Status: NOT_YET_RECRUITING
-
The Exercise Capacity and Quality of Life in the Patients With IPAH and Secondary PH
NCT02647060 ·Status: COMPLETED
-
Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF
NCT03541603 ·Status: COMPLETED ·Phase: PHASE2
-
An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
NCT07234032 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Acute Effects of rhBNP in Patients With PH Associated With Acute Exacerbation of Chronic Pulmonary Disease
NCT02742909 ·Status: COMPLETED ·Phase: PHASE4
-
A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD)
NCT03496623 ·Status: TERMINATED ·Phase: PHASE3
-
Neuromodulation in Patients With Pulmonary Arterial Hypertension
NCT06802380 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
The Effects of Pulmonary Hypertension Web-Based Health Care Program on Symptom Management, Social Support, Activity Tolerance, and Quality of Life in Patients With Pulmonary Hypertension.
NCT05908019 ·Status: UNKNOWN ·Phase: NA
-
A Study on the Efficacy and Safety of Empagliflozin in the Treatment of Pulmonary Arterial Hypertension
NCT06554301 ·Status: RECRUITING ·Phase: PHASE1
-
Oral Nitrite in Patients With Pulmonary Hypertension and Heart Failure With Preserved Ejection Fraction
NCT03015402 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study to Assess the Efficacy, Safety and Tolerability of Macitentan in Subjects With Inoperable Chronic Thromboembolic Pulmonary Hypertension
NCT02021292 ·Status: COMPLETED ·Phase: PHASE2
-
Exhaled Breath Olfactory Signature of Pulmonary Arterial Hypertension
NCT02782026 ·Status: COMPLETED ·Phase: NA
-
Effect of Long-term Oxygen Therapy on Exercise Capacity and Quality of Life in Patients With Pulmonary Arterial and Chronic Thromboembolic Pulmonary Hypertension
NCT01884012 ·Status: COMPLETED ·Phase: PHASE3